• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Rectal Cancer in West China: Younger Onset, Poor Survival, and Poor Compliance.中国西部的直肠癌：发病年龄较轻、生存率低且依从性差。
Dis Colon Rectum. 2021 Jun 1;64(6):639-641. doi: 10.1097/DCR.0000000000002044.
2
Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.辅助治疗依从性和吻合口漏对直肠癌患者根治性切除术后肿瘤学结局的影响。
Dis Colon Rectum. 2021 Jun 1;64(6):689-696. doi: 10.1097/DCR.0000000000001824.
3
Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.局部进展期直肠癌患者的辅助化疗应用：单中心经验。
Clin Colorectal Cancer. 2020 Sep;19(3):e124-e128. doi: 10.1016/j.clcc.2020.03.008. Epub 2020 Apr 14.
4
Prognostic Impact of Extranodal Extension in Rectal Cancer Patients Undergoing Radical Resection After Preoperative Chemoradiotherapy.术前放化疗后行根治性切除术的直肠癌患者的结外侵犯对预后的影响。
Clin Colorectal Cancer. 2021 Mar;20(1):e35-e42. doi: 10.1016/j.clcc.2020.08.004. Epub 2020 Aug 19.
5
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).NORAD01-GRECCAR16 多中心 III 期非劣效性随机试验，比较术前改良 FOLFIRINOX 不联合放疗与放化疗治疗可切除局部进展期直肠癌（法国 GRECCAR-PRODIGE 研究组）。
BMC Cancer. 2020 May 29;20(1):485. doi: 10.1186/s12885-020-06968-1.
6
Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision: A Multi-institutional and Case-matched Control Study.术前放化疗和全直肠系膜切除术治疗老年直肠癌患者的肿瘤学结局和发病率：多机构和病例匹配对照研究。
Ann Surg. 2019 Jan;269(1):108-113. doi: 10.1097/SLA.0000000000002443.
7
The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.根治性全直肠系膜切除术中局部进展期直肠癌的放化疗对复发和生存的影响：一项前瞻性、非随机研究。
World J Surg Oncol. 2017 Nov 22;15(1):205. doi: 10.1186/s12957-017-1275-4.
8
Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.多模式疗法治疗直肠癌可提高生存率并降低局部复发率——一项超过二十年的回顾性分析
BMC Cancer. 2014 Nov 6;14:816. doi: 10.1186/1471-2407-14-816.
9
Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.高危T1至T2期低位直肠癌局部切除术后的术后放化疗：一项单臂、多机构、II期临床试验的结果
Dis Colon Rectum. 2017 Sep;60(9):914-921. doi: 10.1097/DCR.0000000000000870.
10
Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.淋巴管血管侵犯是接受术前放化疗后行全直肠系膜切除术的直肠癌患者的重要预后预测指标。
Ann Surg Oncol. 2012 Apr;19(4):1213-21. doi: 10.1245/s10434-011-2062-z. Epub 2011 Sep 21.

引用本文的文献

1
Trends in disease characteristics and premature mortality among hospitalised middle-aged patients in Anhui Southern Area, China, between 2011 and 2020: a cross-sectional study.2011年至2020年中国安徽南部地区住院中年患者的疾病特征和过早死亡率趋势：一项横断面研究。
BMJ Open. 2024 Dec 10;14(12):e085978. doi: 10.1136/bmjopen-2024-085978.

Rectal Cancer in West China: Younger Onset, Poor Survival, and Poor Compliance.

作者信息

Fang Chao, Yang Lie, Yu Yongyang, Wang Cun, Zhou Zongguang

机构信息

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Dis Colon Rectum. 2021 Jun 1;64(6):639-641. doi: 10.1097/DCR.0000000000002044.

DOI:10.1097/DCR.0000000000002044
PMID:33769324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8096311/
Abstract
摘要